211 related articles for article (PubMed ID: 12056330)
1. Reassessment of the cancer mortality risk among Hiroshima atomic-bomb survivors using a new dosimetry system, ABS2000D, compared with ABS93D.
Katayama H; Matsuura M; Endo S; Hoshi M; Ohtaki M; Hayakawa N
J Radiat Res; 2002 Mar; 43(1):53-64. PubMed ID: 12056330
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cancer mortality among atomic bomb survivors registered at Hiroshima University.
Matsuura M; Hoshi M; Hayakawa N; Shimokata H; Ohtaki M; Ikeuchi M; Kasagi F
Int J Radiat Biol; 1997 May; 71(5):603-11. PubMed ID: 9191905
[TBL] [Abstract][Full Text] [Related]
3. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
Preston DL; Pierce DA; Shimizu Y; Cullings HM; Fujita S; Funamoto S; Kodama K
Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
[TBL] [Abstract][Full Text] [Related]
4. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
[TBL] [Abstract][Full Text] [Related]
5. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
[TBL] [Abstract][Full Text] [Related]
6. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
[TBL] [Abstract][Full Text] [Related]
7. Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry.
Hoshi M; Matsuura M; Hayakawa N; Ito C; Kamada N
Health Phys; 1996 May; 70(5):735-40. PubMed ID: 8690587
[TBL] [Abstract][Full Text] [Related]
8. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.
Preston DL; Pierce DA
Radiat Res; 1988 Jun; 114(3):437-66. PubMed ID: 3375435
[TBL] [Abstract][Full Text] [Related]
9. A parallel analysis of cancer mortality among atomic bomb survivors and patients with ankylosing spondylitis given X-ray therapy.
Darby SC; Nakashima E; Kato H
J Natl Cancer Inst; 1985 Jul; 75(1):1-21. PubMed ID: 3859683
[TBL] [Abstract][Full Text] [Related]
10. Prospects and status of the dosimetry system for atomic bomb survivor cohort study conducted at Research Institute for Radiation Biology and Medicine of Hiroshima University.
Hirota S; Yasuda H; Kawakami H; Yoshinaga S
J Radiat Res; 2021 May; 62(Supplement_1):i107-i113. PubMed ID: 33978168
[TBL] [Abstract][Full Text] [Related]
11. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
Shimizu Y; Kato H; Schull WJ
Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
[TBL] [Abstract][Full Text] [Related]
12. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
[TBL] [Abstract][Full Text] [Related]
14. [Radiation risks. Results of the new evaluation].
Kellerer AM
Radiologe; 1991 May; 31(5):227-34. PubMed ID: 1876693
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation.
Shimizu Y; Schull WJ; Kato H
JAMA; 1990 Aug; 264(5):601-4. PubMed ID: 2366300
[TBL] [Abstract][Full Text] [Related]
16. New dosimetry of atomic bomb radiations.
Fry RJ; Sinclair WK
Lancet; 1987 Oct; 2(8563):845-8. PubMed ID: 2889042
[TBL] [Abstract][Full Text] [Related]
17. Mortality among atomic bomb survivors.
Shimizu Y; Kato H; Schull WJ
J Radiat Res; 1991 Mar; 32 Suppl():212-30. PubMed ID: 1762109
[TBL] [Abstract][Full Text] [Related]
18. Neutrons at Hiroshima: how their disappearance affected risk estimates.
Ellett WH
Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cancer mortality among atomic bomb survivors in Hiroshima Prefecture, 1968-1997.
Zhunussova T; Matsuura M; Hayakawa N
Hiroshima J Med Sci; 2003 Mar; 52(1):1-7. PubMed ID: 12701647
[TBL] [Abstract][Full Text] [Related]
20. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
